tolvaptan has been researched along with Systolic Heart Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnett, J; Gheorghiade, M; Grinfeld, L; Hauptman, PJ; Konstam, MA; Kostic, D; Krasa, HB; Maggioni, A; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C | 1 |
| Frivold, G; Gheorghiade, M; Haught, WH; Konstam, MA; Krasa, H; Macarie, C; Meymandi, S; Orlandi, C; Ouyang, J; Raef, D; Udelson, JE; Wedge, P; Zimmer, CA | 1 |
| Bilsker, M; Hauptman, PJ; Konstam, MA; O'Brien, T; Orlandi, C; Sequeira, R; Thomas, I; Udelson, JE; Zimmer, C | 1 |
| Burnett, JC; Costello-Boerrigter, LC | 1 |
| Bonow, RO; Fought, AJ; Gheorghiade, M; Huffman, M; Konstam, M; Kwasny, MJ; Maggioni, AP; Mentz, RJ; Nodari, S; Sarma, S; Subacius, H; Swedberg, K; Zannad, F | 1 |
4 trial(s) available for tolvaptan and Systolic Heart Failure
| Article | Year |
|---|---|
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.
Topics: Aged; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Dyspnea; Female; Furosemide; Heart Failure, Systolic; Humans; Hyponatremia; Male; Middle Aged; Proportional Hazards Models; Tolvaptan; Weight Loss | 2013 |
Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heart Failure, Systolic; Heart Function Tests; Hemodynamics; Humans; International Cooperation; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Receptors, Vasopressin; Reference Values; Risk Assessment; Severity of Illness Index; Survival Rate; Tolvaptan; Treatment Outcome | 2008 |
A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Heart Failure, Systolic; Humans; Male; Middle Aged; Statistics as Topic; Stroke Volume; Tolvaptan; Vasopressins; Ventricular Function, Left | 2011 |
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cause of Death; Combined Modality Therapy; Comorbidity; Cross-Sectional Studies; Diabetes Complications; Diet, Diabetic; Disease Progression; Female; Follow-Up Studies; Heart Failure, Systolic; Hospitalization; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Patient Discharge; Proportional Hazards Models; Tolvaptan; Treatment Outcome | 2013 |
1 other study(ies) available for tolvaptan and Systolic Heart Failure
| Article | Year |
|---|---|
Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Female; Furosemide; Heart Failure; Heart Failure, Systolic; Humans; Kidney; Male; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan | 2011 |